Seres Therapeutics, Inc. (MCRB) quarterly cash flow statement — complete operating, investing & financing history
Seres Therapeutics, Inc. (MCRB) cash flow statement — 14-year operating, investing & financing cash flows
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 |
|---|
| Cash from Operations | -22.39M | -16.36M | -14.71M | 2.21M | -13.29M | 26.91M | -38.88M | -34.68M | -39.81M | -35.24M | -47.5M | -59.26M | 65.98M | -76.58M | -52.89M | -59.58M | -49.9M | -66.44M | -51.86M | 127.74M |
| Operating CF Margin % | -3042.66% | -4569.83% | -3358.45% | 628.49% | - | - | - | - | - | - | -74217.19% | - | 52.17% | 14671.26% | -5424.82% | -1730.02% | -4103.37% | -4450.44% | -718.22% | 100.8% |
| Operating CF Growth % | -68.52% | -160.8% | 62.17% | 106.36% | 66.62% | 176.37% | 18.14% | 41.47% | -160.33% | 53.99% | 10.2% | 0.55% | 232.24% | -15.26% | -1.98% | -146.64% | -25.7% | -125.27% | -189.3% | 593.86% |
| Net Income | 4.58M | -19.91M | -15.34M | 8.2M | -19.86M | 32.68M | -15.64M | 88.78M | -32.87M | -40.13M | -34.72M | -41.02M | 46.55M | -71.17M | -68.8M | -60M | -64.73M | -56.62M | -50M | 68.22M |
| Depreciation & Amortization | 670K | 781K | 954K | 1.04M | 1.06M | 1.08M | 1.08M | 1.4M | 1.42M | 1.56M | 10.5M | 1.68M | 1.53M | 1.4M | 1.63M | 1.75M | 1.69M | 1.57M | 1.55M | 1.49M |
| Stock-Based Compensation | 1.74M | 1.77M | 3.2M | 2.48M | 2.34M | 2.82M | 3.77M | 5.18M | 5.53M | 6.49M | 0 | 0 | 13.49M | 6.85M | 7.29M | 6.36M | 6.75M | 5.08M | 5.67M | 5.85M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 7.89M | 2.25M | 1.99M | 2.13M | 2.06M | 2.04M | 2.03M | -155.83M | 2.74M | 6M | -7.9M | 2.86M | 5.88M | 5.68M | 2.49M | 2.66M | 1.95M | 528K | 937K | 343K |
| Working Capital Changes | -37.28M | -1.25M | -5.52M | -11.65M | 1.1M | -11.71M | -30.13M | 25.79M | -16.64M | -9.15M | -15.39M | -22.79M | -1.46M | -19.34M | 4.5M | -10.35M | 4.46M | -17M | -10.03M | 51.84M |
| Change in Receivables | -25.04M | 284K | 260K | 105K | 1.88M | -693K | -2.07M | 9.93M | -11.18M | 1.26M | 8.18M | -9.3M | -7.56M | 0 | 0 | 0 | 0 | 0 | 1.25M | 1K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -10.45M | -11.02M | -12.33M | -11.12M | -13.19M | -5.34M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -1.15M | 656K | 5K | -515K | 79K | -1.97M | -4.16M | 38K | -410K | 1.59M | -5.04M | -3.45M | 714K | -3.81M | 5.45M | -3.96M | 7.17M | -6.46M | 4.58M | 3.1M |
| Cash from Investing | 14K | 0 | 181K | -8K | -181K | -34K | -90K | 141.14M | 1.3M | -62K | -877K | -1.8M | 10.52M | 2.74M | 5.93M | 40.13M | 23.4M | 12.97M | 13.19M | 25.11M |
| Capital Expenditures | 14K | 0 | -29K | -8K | -181K | -34K | -90K | -129K | -99K | -62K | -877K | -1.8M | -1.23M | -4.07M | -3.46M | -1.25M | -2.16M | -2.95M | -1.58M | -4.09M |
| CapEx % of Revenue | 1.9% | - | 6.62% | 2.28% | - | - | - | - | - | - | 1370.31% | - | 0.97% | -779.31% | 354.97% | 36.21% | 177.88% | 197.59% | 21.85% | 3.23% |
| Acquisitions | 0 | 0 | 210K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -6.81M | -9.39M | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 127.76M | 1.4M | 0 | 0 | 0 | 0 | 6.81M | 9.39M | 0 | 0 | 0 | 750K | 0 |
| Cash from Financing | 1.72M | 428K | 12.66M | 61K | 0 | 1.18M | 1.74M | -110.87M | 0 | 18.76M | 6.43M | 1.44M | 58.18M | 5.66M | 4.6M | 98.03M | 130K | 26.85M | -780K | 609K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 127.91M | -127.91M | 0 | 0 | 0 | 0 | 50.52M | 0 | 0 | 0 | 0 | 25.7M | -948K | 0 |
| Equity Issued (Net) | 1.72M | 428K | 12.66M | 61K | 0 | 1.18M | 1.74M | 3.38M | 0 | 18.41M | 6.43M | 1.44M | 7.49M | 4.24M | 1.17M | 100M | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 0 | -127.91M | 13.65M | 0 | 353K | 0 | 0 | 168K | 1.42M | 3.43M | -1.97M | 130K | 1.15M | 168K | 609K |
| Net Change in Cash | -20.66M | -15.93M | -1.87M | 2.26M | -13.47M | 28.06M | -37.24M | -4.41M | -38.51M | -16.78M | -41.95M | -59.61M | 134.68M | -68.19M | -42.37M | 78.57M | -26.37M | -26.63M | -39.46M | 153.46M |
| Free Cash Flow | -22.39M | -16.36M | -14.74M | 2.2M | -13.47M | 26.88M | -38.97M | -34.81M | -39.91M | -35.3M | -48.38M | -61.05M | 64.75M | -80.65M | -56.35M | -60.83M | -52.06M | -69.39M | -53.44M | 123.65M |
| FCF Margin % | -3042.66% | -4569.83% | -3365.07% | 626.21% | - | - | - | - | - | - | -75587.5% | - | 51.2% | 15450.57% | -5779.79% | -1766.23% | -4281.25% | -4648.02% | -740.08% | 97.57% |
| FCF Growth % | -66.25% | -160.87% | 62.18% | 106.31% | 66.25% | 176.14% | 19.44% | 42.98% | -161.64% | 56.23% | 14.16% | -0.37% | 224.38% | -16.22% | -5.45% | -149.19% | -23.22% | -125.03% | -194.39% | 576.82% |
| FCF per Share | -2.32 | -1.71 | -1.66 | 0.25 | -1.54 | 3.08 | -4.51 | -4.56 | -5.27 | -4.83 | -7.48 | -9.52 | 9.97 | -12.82 | -9.00 | -9.93 | -11.29 | -15.06 | -11.63 | 26.04 |
| FCF Conversion (FCF/Net Income) | -4.89x | 0.82x | 0.96x | 0.27x | 0.67x | 0.82x | 2.49x | -0.39x | 1.21x | 0.88x | 1.15x | 1.24x | 1.42x | 1.08x | 0.77x | 0.99x | 0.77x | 1.17x | 1.04x | 1.87x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.13M | 0 | 0 | 1.45M | 1.28M | 558K | 610K | 616K |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |